Panjon Limited held its 43rd Annual General Meeting on September 30, 2026, adopting the audited financial statements for FY26 and approving key board appointments.

The meeting, chaired by Managing Director Jay Kothari, commenced at 12:00 pm and concluded by 1:00 pm at the company's registered office in Indore. A total of 33 members attended physically, while remote e-voting was facilitated through NSDL prior to the event. The requisite quorum was present to transact the business outlined in the notice dated August 13, 2026.

Key resolutions passed

Shareholders approved three primary agenda items during the session. The audited financial statements for the fiscal year ended March 31, 2026, along with the Board of Directors' and Auditors' reports, were adopted via an ordinary resolution.

In terms of board composition, Mrs. Anju Kothari was re-appointed as a Director in place of her retirement by rotation. Additionally, Mr. Archit Kothari was appointed as a Non-Executive Non-Independent Director, regularizing his position on the board. Both appointments were passed through ordinary resolutions.

Voting and procedural details

The company disclosed that voting results and the scrutinizer's report would be made available to stock exchanges and published on company websites by October 3, 2026. CS Parul Dwivedi served as the scrutinizer to ensure fair and transparent voting processes across electronic and physical ballots. The Chairman thanked members for their continued support and participation in the governance process.

Panjon has scheduled its 43rd Annual General Meeting (AGM) for Wednesday, September 30, 2026, at 12:00 pm via Video Conferencing. The meeting will transact ordinary business, including the adoption of audited financial statements for FY26 and the re-appointment of Executive Director Mrs. Anju Kothari.

The pharmaceutical and consumer products manufacturer reported revenue of ₹476.2 crore for FY26, marking a 56.35% increase from ₹304.6 crore in the previous year. Net profit rose 20.23% to ₹47.6 crore, driven by operational growth and tax adjustments.

Financial Performance

The company's top-line expansion was supported by higher sales volumes and increased purchases of finished goods. While other income dipped slightly by 2.33%, the overall profitability improved significantly.

Total expenditure rose to ₹471.9 crore from ₹302.4 crore, reflecting the scale-up in operations. Finance costs increased to ₹27.1 crore from ₹17.1 crore, while employee benefit expenses grew to ₹89.1 crore.

What the Numbers Show

Revenue growth significantly outpaced the rise in total expenditure, leading to an expansion in Profit Before Tax (PBT). PBT grew by 37.35%, whereas Net Profit grew by 20.23%. This divergence is primarily due to a reduction in total tax expenses, which turned negative (a benefit) of ₹24.8 crore in FY26 compared to ₹13.2 crore in FY25, largely driven by deferred tax assets.

Corporate Governance and Board Changes

The AGM agenda includes the regularization of Mr. Archit Kothari as a Non-Executive Non-Independent Director. He was appointed as an Additional Director on August 13, 2026, and seeks shareholder approval to continue his tenure. Key governance disclosures include:

• Auditor Appointment Non-Compliance: The Secretarial Audit Report noted that the Board appointed M/s Goyal Parul & Co. as Statutory Auditors without shareholder approval, deviating from the resolution passed at the 41st AGM which had re-appointed M/s Giriraj & Lohiya.
• Related Party Transactions: Significant transactions were recorded with Sanitex Chemical Limited, where Mrs. Anju Kothari serves as a director. Sales to the entity amounted to ₹4.8 crore, while purchases stood at ₹84.7 lakh.
• Dividend: No dividend was recommended for the year due to working capital requirements.

Meeting Details

Shareholders holding shares as of the cut-off date, Wednesday, September 23, 2026, are eligible to vote. Remote e-voting will be open from Sunday, September 27, 2026, at 9:00 am to Tuesday, September 29, 2026, at 5:00 pm.